Minerva Neurosciences
NERV
22 hedge funds and large institutions have $4.63M invested in Minerva Neurosciences in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
5% more funds holding
Funds holding: 21 → 22 (+1)
0.46% less ownership
Funds ownership: 30.3% → 29.84% (-0.46%)
18% less capital invested
Capital invested by funds: $5.65M → $4.63M (-$1.02M)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$32.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$20.1K |
| 3 |
Morgan Stanley
New York
|
+$12.6K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.65K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$146 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$68.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$54K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$24.9K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$3.14K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.1K |
NERV Hedge Fund Activity: Q4 2024 in Review
22 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2024, worth a combined $4.63M — down 18% from $5.65M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NERV positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Northern Trust, adding an estimated $32.6K. The largest seller was Renaissance Technologies, cutting an estimated $68.7K.
- 22 institutional investors held Minerva Neurosciences (NERV) as of Q4 2024, up from 21 in Q3 2024.
- Funds reported $4.63M of Minerva Neurosciences stock for Q4 2024, down 18% quarter-over-quarter.
- 4 funds opened new Minerva Neurosciences positions in Q4 2024 and 3 closed out, a net change of +1 holder.
- The largest Minerva Neurosciences buyer in Q4 2024 was Northern Trust, an estimated $32.6K added.
- The largest Minerva Neurosciences seller in Q4 2024 was Renaissance Technologies, an estimated $68.7K sold.
Based on aggregated 13F filings for Q4 2024.